Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
about
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficitsIdentification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for TauopathiesTau-mediated synaptic damage in Alzheimer's diseaseIs glial heme oxygenase-1 suppression in neurodegenerative disorders permissive for neural repair?Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.Rescue of tau-induced synaptic transmission pathology by paclitaxel.COPS5 protein overexpression increases amyloid plaque burden, decreases spinophilin-immunoreactive puncta, and exacerbates learning and memory deficits in the mouse brainTemplated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds.Soluble forms of tau are toxic in Alzheimer's disease.Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.Synaptic alterations in the rTg4510 mouse model of tauopathy.Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease.Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.Physiological and Pathophysiological Implications of Synaptic Tau.Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat.Anti-aggregant tau mutant promotes neurogenesis.
P2860
Q27314989-7D8E46F8-75A4-4B1B-8473-CF942F2DF021Q28597211-63A165FE-9F20-4983-9467-89C982309303Q28831067-81B42CAF-5862-426F-9322-868F13FBC007Q30414246-EAA35AE5-CAAE-4173-8541-D45FC528ACAAQ34329880-EBDCC7DE-9BE0-4929-9FD3-B4DDC3CB2F09Q35103703-C2495C9F-71C8-4B58-8964-12B7F4C46F6CQ35580909-B8886B20-4A8C-4957-B009-6F9778E0419EQ35622023-EF0697F2-E083-48C5-BB85-385644C7D7D0Q36047276-BCEE41FF-5C12-411F-8F45-23ACB4802660Q36286360-4B609735-1800-4526-9CDE-D9EED50EF0A6Q36391178-63E6A7BD-E27A-4645-8A20-0DB0BD80D912Q37051901-2E4EB6DF-D285-4CF9-9F3A-319028D73106Q37093852-80AF5970-7247-4184-9D59-AAF28C8D45BFQ38091721-A08A7EC0-C0E0-429A-AAC5-5D6974D22BCDQ38747530-E6B787DA-C197-4B5E-9959-3031F057A27BQ40415700-F7AC2111-3CF2-452E-A376-902C9649D3DEQ46237544-7819ED8F-0A8F-4720-BDA2-BED522A7DD63Q47116879-A68D4D5C-5DFF-497C-850C-3ED53170A35A
P2860
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@en
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@nl
type
label
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@en
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@nl
prefLabel
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@en
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@nl
P2093
P2860
P50
P1476
Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
@en
P2093
Astrid Sydow
Christian Alzheimer
Dagmar Drexler
Detlef Balschun
Fang Zheng
Gabriele Rune
Olga Petrova
Rudi D'Hooge
P2860
P2888
P304
P356
10.1007/S12031-011-9604-5
P577
2011-08-06T00:00:00Z